Actavis Standard Transcends Cash Deals, FTC Tells 3rd Circ.
The Federal Trade Commission on Monday urged the Third Circuit to revive a proposed antitrust class action against GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. over a deal to postpone generics...To view the full article, register now.
Already a subscriber? Click here to view full article